Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 12:14 AM
Ignite Modification Date:
2025-12-25 @ 12:14 AM
NCT ID:
NCT00628758
Eligibility Criteria:
Inclusion Criteria:
* Signed informed consent form. If the patient cannot read and write, verbal consent from the patient is required.
* Ability to read and write in Turkish
* Female or male outpatients aged 18 years
* Minimum of 3 months history of asthma, diagnosed according to the American Thoracic Society (ATS) definition
* Prescribed inhaled glucocorticosteroid (GCS) at a dose of 320mg/day and within the approved label for the relevant drug during the last 3 months prior to Visit 1
* Either: daily maintenance treatment with both inhaled GCS and long-acting b2-agonist (LABA) or daily treatment with inhaled GCS alone (i.e. without LABA); and a history of suboptimal asthma control the month prior to enrollment as judged by the investigator; and use of 3 Peak Expiratory Flow inhalations ofas needed medication for symptom relief during the last 7 days before enrollment
Exclusion Criteria:
* Previous treatment with Symbicort Single inhaler Therapy
* Use of any b-blocking agent, including eye drops
* Use of oral GCS as maintenance treatment
* Known or suspected hypersensitivity to study therapy or excipients
* A history of smoking 10 pack years
* Pregnancy, breast-feeding or planned pregnancy during the study. Fertile women not using acceptable contraceptive measures, as judged by the investigator
* Any significant disease or disorder, which, in the opinion of the investigator, may put the patient at risk because of participating in the study
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT00628758
Study Brief:
Protocol Section:
NCT00628758